Forty51 Ventures
Europe, Basel-Stadt, Switzerland, Basel
Description
Forty51 Ventures is the Biotech Venture Capital.
Investor Profile
Forty51 Ventures has backed more than 5 startups, with 1 new investments in the last 12 months alone. The firm has led 3 rounds, about 60% of its total and boasts 0 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Seed, Series A rounds (top funding stages).
- Majority of deals are located in Switzerland, United States.
- Strong thematic focus on Therapeutics, Biotechnology, Pharmaceutical.
Stage Focus
- Seed (80%)
- Series A (20%)
Country Focus
- Switzerland (80%)
- United States (20%)
Industry Focus
- Therapeutics
- Biotechnology
- Pharmaceutical
- Health Care
- Medical
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
